EMEA-002915-PIP01-20

Table of contents

Key facts

Active substance
SARS-CoV2 prefusion Spike delta TM (CoV-2 preS dTM) adjuvanted with AS03
Therapeutic area
Vaccines
Decision number
P/0201/2021
PIP number
EMEA-002915-PIP01-20
Pharmaceutical form(s)
Solution and emulsion for emulsion for injection
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
Intramuscular use
Contact for public enquiries
Sanofi pasteur

E-mail: contact-us@sanofi.com
Tel. +33 1 6974 5695

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating
Average
1 rating